Vertex Pharmaceuticals Quick Ratio 2006-2019 | VRTX

Historical quick ratio values for Vertex Pharmaceuticals (VRTX) over the last 10 years.
Vertex Pharmaceuticals Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2019-12-31 $4.66B $1.34B 3.49
2019-09-30 $4.62B $1.39B 3.32
2019-06-30 $4.57B $1.26B 3.63
2019-03-31 $4.05B $1.11B 3.66
2018-12-31 $3.72B $1.12B 3.32
2018-09-30 $3.56B $0.99B 3.59
2018-06-30 $3.29B $0.93B 3.55
2018-03-31 $2.92B $0.83B 3.53
2017-12-31 $2.54B $0.81B 3.14
2017-09-30 $2.23B $0.71B 3.14
2017-06-30 $2.09B $0.63B 3.34
2017-03-31 $1.79B $0.49B 3.65
2016-12-31 $1.75B $0.79B 2.21
2016-09-30 $1.43B $0.72B 1.98
2016-06-30 $1.39B $0.62B 2.23
2016-03-31 $1.34B $0.55B 2.43
2015-12-31 $1.35B $0.51B 2.67
2015-09-30 $1.31B $0.38B 3.49
2015-06-30 $1.25B $0.37B 3.35
2015-03-31 $1.32B $0.30B 4.38
2014-12-31 $1.52B $0.37B 4.12
2014-09-30 $1.63B $0.37B 4.39
2014-06-30 $1.34B $0.36B 3.68
2014-03-31 $1.42B $0.37B 3.80
2013-12-31 $1.57B $0.40B 3.96
2013-09-30 $1.64B $0.41B 3.99
2013-06-30 $1.70B $0.38B 4.45
2013-03-31 $1.54B $0.41B 3.79
2012-12-31 $1.56B $0.43B 3.60
2012-09-30 $1.55B $0.41B 3.81
2012-06-30 $1.51B $0.38B 3.97
2012-03-31 $1.31B $0.36B 3.66
2011-12-31 $1.22B $0.39B 3.11
2011-09-30 $1.18B $0.55B 2.15
2011-06-30 $0.78B $0.48B 1.62
2011-03-31 $0.86B $0.42B 2.06
2010-12-31 $0.00B $0.48B 0.00
2010-09-30 $0.00B $0.31B 0.00
2010-06-30 $0.00B $0.29B 0.00
2010-03-31 $0.00B $0.21B 0.00
2009-12-31 $0.00B $0.29B 0.00
2009-09-30 $0.00B $0.23B 0.00
2009-06-30 $0.00B $0.18B 0.00
2009-03-31 $0.00B $0.18B 0.00
2008-12-31 $0.00B $0.22B 0.00
2008-09-30 $0.00B $0.18B 0.00
2008-06-30 $0.00B $0.18B 0.00
2008-03-31 $0.00B $0.17B 0.00
2007-12-31 $0.00B $0.20B 0.00
2007-09-30 $0.00B $0.19B 0.00
2007-06-30 $0.00B $0.20B 0.00
2007-03-31 $0.00B $0.18B 0.00
2006-12-31 $0.00B $0.25B 0.00
2006-09-30 $0.00B $0.16B 0.00
2006-06-30 $0.00B $0.11B 0.00
2006-03-31 $0.00B $0.08B 0.00
2005-12-31 $0.00B $0.10B 0.00
2005-09-30 $0.00B $0.12B 0.00
2005-06-30 $0.00B $0.14B 0.00
2005-03-31 $0.00B $0.15B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $66.191B $4.163B
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $124.791B 14.27
Gilead Sciences (GILD) United States $97.863B 12.66
CSL (CSLLY) Australia $90.292B 0.00
Regeneron Pharmaceuticals (REGN) United States $55.479B 23.50
Biogen (BIIB) United States $54.202B 9.26
Illumina (ILMN) United States $40.867B 42.25
Seattle Genetics (SGEN) United States $21.467B 0.00
Alexion Pharmaceuticals (ALXN) United States $21.302B 9.88
Incyte (INCY) United States $18.450B 39.59
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.127B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.892B 636.69
Genmab (GMAB) Denmark $14.017B 10.88
Galapagos (GLPG) Belgium $13.121B 40.10
Genmab (GNMSF) Denmark $13.109B 42.16
Alnylam Pharmaceuticals (ALNY) United States $12.680B 0.00
BioNTech SE (BNTX) Germany $11.931B 0.00
Moderna (MRNA) United States $11.397B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.292B 52.78
BeiGene (BGNE) Cayman Islands $9.396B 0.00
Exact Sciences (EXAS) United States $9.214B 0.00
QIAGEN (QGEN) Netherlands $9.110B 27.78
Sarepta Therapeutics (SRPT) United States $7.861B 0.00
Bio-Techne Corp (TECH) United States $7.461B 51.06
ACADIA Pharmaceuticals (ACAD) United States $6.725B 0.00
Guardant Health (GH) United States $6.323B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.077B 16.06
ARGENX SE-ADR (ARGX) Netherlands $5.853B 0.00
Ascendis Pharma (ASND) Denmark $5.649B 0.00
Exelixis (EXEL) United States $5.396B 17.32
Repligen (RGEN) United States $5.245B 95.91
Acceleron Pharma (XLRN) United States $4.652B 0.00
Reata Pharmaceuticals (RETA) United States $4.595B 0.00
Vir Biotechnology (VIR) United States $4.030B 0.00
Immunomedics (IMMU) United States $4.018B 0.00
China Biologic Products (CBPO) China $3.903B 23.17
Adaptive Biotechnologies (ADPT) United States $3.550B 0.00
Blueprint Medicines (BPMC) United States $3.546B 0.00
Global Blood Therapeutics (GBT) United States $3.492B 0.00
Mirati Therapeutics (MRTX) United States $3.433B 0.00
MorphoSys AG (MOR) Germany $3.340B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.284B 0.00
Emergent Biosolutions (EBS) United States $3.190B 22.14
Zai Lab (ZLAB) China $3.047B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.979B 0.00
NeoGenomics (NEO) United States $2.747B 119.09
CRISPR Therapeutics AG (CRSP) Switzerland $2.568B 43.47
Amicus Therapeutics (FOLD) United States $2.531B 0.00
Bluebird Bio (BLUE) United States $2.411B 0.00
Alkermes (ALKS) Ireland $2.390B 189.38
Halozyme Therapeutics (HALO) United States $2.383B 0.00
Arena Pharmaceuticals (ARNA) United States $2.379B 6.20
Deciphera Pharmaceuticals (DCPH) United States $2.350B 0.00
MyoKardia (MYOK) United States $2.238B 0.00
UniQure (QURE) Netherlands $2.116B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.065B 0.00
Denali Therapeutics (DNLI) United States $1.976B 0.00
Principia Biopharma (PRNB) United States $1.914B 0.00
Fate Therapeutics (FATE) United States $1.883B 0.00
Alector (ALEC) United States $1.840B 0.00
Amarin (AMRN) Ireland $1.715B 0.00
Eidos Therapeutics (EIDX) United States $1.690B 0.00
Arvinas (ARVN) United States $1.664B 0.00
Zymeworks (ZYME) Canada $1.646B 0.00
Insmed (INSM) United States $1.597B 0.00
Akcea Therapeutics (AKCA) United States $1.592B 34.24
Viela Bio (VIE) United States $1.556B 0.00
Epizyme (EPZM) United States $1.540B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.461B 0.00
Ligand Pharmaceuticals (LGND) United States $1.278B 39.71
Inovio Pharmaceuticals (INO) United States $1.230B 0.00
Zealand Pharma (ZEAL) Denmark $1.187B 0.00
Editas Medicine (EDIT) United States $1.172B 0.00
Myriad Genetics (MYGN) United States $1.142B 20.16
Coherus BioSciences (CHRS) United States $1.126B 13.40
REGENXBIO (RGNX) United States $1.117B 0.00
PHARMA MAR SA (PHMMF) Spain $1.107B 0.00
Twist Bioscience (TWST) United States $1.054B 0.00
NextCure (NXTC) United States $1.032B 0.00
NGM Biopharmaceuticals (NGM) United States $0.908B 0.00
Revance Therapeutics (RVNC) United States $0.887B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Intra-Cellular Therapies (ITCI) United States $0.858B 0.00
Beam Therapeutics (BEAM) United States $0.855B 0.00
Novavax (NVAX) United States $0.830B 0.00
Adverum Biotechnologies (ADVM) United States $0.794B 0.00
I-Mab (IMAB) China $0.787B 0.00
Sangamo Therapeutics (SGMO) United States $0.787B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.756B 0.00
Cytokineticsorporated (CYTK) United States $0.741B 0.00
Arcus Biosciences (RCUS) United States $0.717B 0.00
Retrophin (RTRX) United States $0.694B 0.00
Bellus Health (BLU) Canada $0.671B 0.00
Athenex (ATNX) United States $0.664B 0.00
Pharming Group (PHGUF) Netherlands $0.663B 0.00
Mesoblast (MESO) Australia $0.662B 0.00
GENFIT S.A (GNFT) France $0.661B 0.00
Cara Therapeutics (CARA) United States $0.626B 0.00
Kadmon Holdings (KDMN) United States $0.622B 0.00
Intellia Therapeutics (NTLA) United States $0.621B 0.00
Codexis (CDXS) United States $0.616B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.589B 5.18
Compugen (CGEN) Israel $0.556B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.556B 0.00
ANI Pharmaceuticals (ANIP) United States $0.523B 9.44
Castle Biosciences (CSTL) United States $0.519B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.513B 0.00
Intrexon (PGEN) United States $0.504B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.500B 0.00
Clovis Oncology (CLVS) United States $0.499B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.497B 0.00
MeiraGTx Holdings (MGTX) United States $0.497B 0.00
AC Immune SA (ACIU) Switzerland $0.489B 12.48
Frequency Therapeutics (FREQ) United States $0.487B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.484B 0.00
Prothena (PRTA) Ireland $0.474B 0.00
Sorrento Therapeutics (SRNE) United States $0.473B 0.00
Athersys (ATHX) United States $0.463B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Morphic Holding (MORF) United States $0.457B 0.00
Heska (HSKA) United States $0.439B 0.00
Scholar Rock Holding (SRRK) United States $0.432B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.424B 0.00
Verastem (VSTM) United States $0.420B 0.00
UROGEN PHARMA (URGN) United States $0.419B 0.00
AnaptysBio (ANAB) United States $0.416B 0.00
Vericel (VCEL) United States $0.414B 61.33
DBV Technologies S.A (DBVT) France $0.413B 0.00
Anika Therapeutics (ANIK) United States $0.412B 14.19
Cel-Sci (CVM) United States $0.409B 0.00
Agenus (AGEN) United States $0.399B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.390B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.382B 0.00
BioDelivery Sciences (BDSI) United States $0.381B 43.89
Cue Biopharma (CUE) United States $0.381B 0.00
MiMedx (MDXG) United States $0.378B 0.00
Cellectis S.A (CLLS) France $0.376B 0.00
CytomX Therapeutics (CTMX) United States $0.364B 0.00
PDL BioPharma (PDLI) United States $0.351B 10.52
Kala Pharmaceuticals (KALA) United States $0.342B 0.00
Merus (MRUS) Netherlands $0.334B 0.00
Pfenex (PFNX) United States $0.306B 446.50
Syndax Pharmaceuticals (SNDX) United States $0.302B 0.00
Puma Biotechnology (PBYI) United States $0.300B 0.00
Syros Pharmaceuticals (SYRS) United States $0.299B 0.00
Cellular Biomedicine (CBMG) United States $0.299B 0.00
NantKwest (NK) United States $0.295B 0.00
Precision BioSciences (DTIL) United States $0.292B 0.00
WAVE Life Sciences (WVE) Singapore $0.289B 0.00
Dynavax Technologies (DVAX) United States $0.280B 0.00
ADMA Biologics Inc (ADMA) United States $0.275B 0.00
Avid Bioservices (CDMO) United States $0.271B 0.00
Kamada (KMDA) Israel $0.269B 11.20
Autolus Therapeutics (AUTL) United Kingdom $0.255B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.250B 0.00
Gritstone Oncology (GRTS) United States $0.246B 0.00
Mersana Therapeutics (MRSN) United States $0.244B 0.00
Stemline Therapeutics (STML) United States $0.240B 0.00
Albireo Pharma (ALBO) United States $0.238B 0.00
Seres Therapeutics (MCRB) United States $0.236B 0.00
Aduro Biotech (ADRO) United States $0.232B 0.00
Sutro Biopharma (STRO) United States $0.229B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.229B 0.00
Geron (GERN) United States $0.224B 0.00
ChromaDex (CDXC) United States $0.209B 0.00
MannKind (MNKD) United States $0.209B 0.00
Starpharma Holdings (SPHRY) Australia $0.201B 0.00
Alcobra (ARCT) United States $0.200B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.199B 1.79
XOMA (XOMA) United States $0.197B 0.00
Abeona Therapeutics (ABEO) United States $0.191B 0.00
Prometic Life Sciences (LMNL) Canada $0.184B 0.00
Protagonist Therapeutics (PTGX) United States $0.183B 0.00
HOOKIPA Pharma (HOOK) United States $0.181B 0.00
VBI Vaccines (VBIV) United States $0.178B 0.00
IVERIC Bio (ISEE) United States $0.170B 0.00
Selecta Biosciences (SELB) United States $0.169B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.163B 0.00
Spero Therapeutics (SPRO) United States $0.162B 0.00
OSMOTICA PHARM (OSMT) United States $0.161B 0.00
Kindred Biosciences (KIN) United States $0.160B 0.00
Liquidia Technologies (LQDA) United States $0.159B 0.00
Fortress Biotech (FBIO) United States $0.157B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.152B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Dyadic (DYAI) United States $0.144B 0.00
Aytu Bioscience (AYTU) United States $0.143B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.141B 0.00
Affimed (AFMD) Germany $0.139B 0.00
VolitionRX (VNRX) United States $0.138B 0.00
Windtree Therapeutics (WINT) United States $0.136B 0.00
Cerecor (CERC) United States $0.135B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Biofrontera AG (BFRA) Germany $0.133B 0.00
Theratechnologies (THTX) Canada $0.129B 0.00
Antibe Therapeutics (ATBPF) Canada $0.127B 0.00
Exicure (XCUR) United States $0.123B 0.00
AIT Therapeutics (XAIR) United States $0.122B 0.00
VTv Therapeutics (VTVT) United States $0.121B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.118B 4.64
Northwest Biotherapeutics (NWBO) United States $0.105B 0.00
Strongbridge Biopharma (SBBP) United States $0.105B 0.00
Celyad SA (CYAD) Belgium $0.103B 0.00
Palatin Technologies (PTN) United States $0.100B 2.73
Cidara Therapeutics (CDTX) United States $0.099B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.098B 0.00
Aptinyx (APTX) United States $0.098B 0.00
TELA Bio (TELA) United States $0.091B 0.00
ARAVIVE, INC (ARAV) United States $0.089B 0.00
IBio (IBIO) United States $0.089B 0.00
CorMedix Inc (CRMD) United States $0.088B 0.00
PHASEBIO PHARMA (PHAS) United States $0.086B 0.00
Five Prime Therapeutics (FPRX) United States $0.086B 0.00
Happiness Biotech Group (HAPP) China $0.085B 0.00
Arbutus Biopharma (ABUS) Canada $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.072B 0.00
Cyclerion Therapeutics (CYCN) United States $0.071B 0.00
Clearside Biomedical (CLSD) United States $0.070B 0.00
Orgenesis (ORGS) United States $0.070B 4.11
Checkpoint Therapeutics (CKPT) United States $0.068B 0.00
Adocia (ADOCY) France $0.066B 0.00
Eton Pharmaceuticals (ETON) United States $0.065B 0.00
Vaccinex (VCNX) United States $0.063B 0.00
Applied Genetic Technologies (AGTC) United States $0.061B 0.00
Emmaus Life Sciences (EMMA) United States $0.061B 0.00
Proteostasis Therapeutics (PTI) United States $0.060B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
SESEN BIO, INC (SESN) United States $0.059B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.057B 0.00
Synlogic (SYBX) United States $0.057B 0.00
AquaBounty Technologies (AQB) United States $0.054B 0.00
Catalyst Biosciences (CBIO) United States $0.052B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.050B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.050B 0.00
Trevena (TRVN) United States $0.048B 0.00
Stealth BioTherapeutics (MITO) United States $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
Acorda Therapeutics (ACOR) United States $0.045B 0.00
Idera Pharmaceuticals (IDRA) United States $0.039B 0.00
Organovo Holdings (ONVO) United States $0.039B 0.00
Cocrystal Pharma (COCP) United States $0.038B 0.00
Advaxis (ADXS) United States $0.038B 0.00
Soligenix (SNGX) United States $0.037B 0.00
Lumos Pharma (LUMO) United States $0.037B 0.00
AmpliPhi Biosciences (ARMP) United States $0.036B 0.00
Protalix BioTherapeutics (PLX) Israel $0.035B 0.00
Menlo Therapeutics (MNLO) United States $0.034B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.034B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
CollPlant Holdings (CLGN) Israel $0.033B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.033B 0.00
Celldex Therapeutics (CLDX) United States $0.031B 0.00
Prima BioMed (IMMP) Australia $0.027B 0.00
Pulmatrix (PULM) United States $0.027B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.027B 0.00
OvaScience (MLND) United States $0.026B 0.00
Celsion (CLSN) United States $0.026B 0.00
Evogene (EVGN) Israel $0.025B 0.00
ATyr Pharma (LIFE) United States $0.025B 0.00
TOCAGEN INC (TOCA) United States $0.025B 0.00
Curis (CRIS) United States $0.024B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
BioCardia (BCDA) United States $0.020B 0.00
Entera Bio (ENTX) Israel $0.020B 0.00
Alimera Sciences (ALIM) United States $0.019B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.018B 0.00
Stellar Biotechnologies (EDSA) Canada $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
Oncobiologics (OTLK) United States $0.017B 0.00
Apricus Biosciences (SEEL) United States $0.017B 0.00
Cesca Therapeutics (THMO) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
VIVUS (VVUS) United States $0.014B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Aptevo Therapeutics (APVO) United States $0.011B 0.00
Unum Therapeutics (UMRX) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
TrovaGene (TROV) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
IMMURON (IMRN) Australia $0.006B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00